Security key
04746L203
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 1,706,896
- Total 13F value
- $7,065,761
- Share change
- +1,706,873
- SEC-reported price per share
- $4.14
- Number of holders
- 32
- Value change
- +$7,065,666
- Number of buys
- 31
- Shares outstanding
- 12,547,689
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
32
Top holders
10
LONA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
LeonaBio, Inc. SEC filings
LeonaBio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04746L203
Recent filing periods:
Ownership snapshot
Top reported holders of LONA - LeonaBio, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Jun 2025
13F
3/4/5
Highest disclosed value: $1,631,695
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $1.63M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
PERCEPTIVE ADVISORS LLC
$1.63M
BML Capital Management, LLC
$975.7K
VANGUARD GROUP INC
$464.4K
Propel Bio Management, LLC
$450.8K
Simplify Asset Management Inc.
$450.8K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$1,631,695
5,402,964 shares
|
— | 30 Jun 2025 |
| BML Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$975,661
3,230,667 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$464,450
1,537,914 shares
|
— | 30 Jun 2025 |
| Propel Bio Management, LLC |
13F
Company
|
—
denominator unverified
|
$450,823
1,492,792 shares
|
— | 30 Jun 2025 |
| Simplify Asset Management Inc. |
13F
Company
|
—
denominator unverified
|
$450,823
1,492,792 shares
|
— | 30 Jun 2025 |
| Hans Moebius |
3/4/5
Chief Medical Officer
|
—
denominator unverified
|
$266,213
91,482 shares
|
— | 04 Jan 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
32
Shares
1,706,896
Rows available
32
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2026 Across Filers
Q2 2026 holders
44
Q3 2025 holders
32
Holder diff
-12
| Investor | Q2 2026 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend